Science
At the forefront of breakthrough science
We accelerate the discovery and development of potential therapies in new and uncharted areas.
We adopt and adapt with agility.
We approach our science through the lens of patient need. We take a collaborative, multidisciplinary approach to discovery, applying adaptable thinking to foster innovation. By flexibly integrating new ideas and technologies, setbacks and uncertainties become opportunities for growth and creativity.
Infinite potential
We’re in. Learn how we strive to advance the next generation of potential medicines through innovative research. From San Diego to Cambridge, UK and everywhere in between.
We’re in. All in.
Our approach to science lets us see the bigger picture
Pipeline
We are advancing a diverse portfolio of approved and mid- to late-stage investigational medicines as well as cutting-edge drug discovery.
Areas of innovation
We are investigating a wide range of technologies and modalities, including gene therapy, AI-driven protein engineering, protein manufacturing, RNA end-joining, and synthetic rescue.
Our innovation engine
Our four laboratories are the driving force behind our research efforts and collaborate seamlessly across geographies. We are pursuing multiple solutions, technologies, and modalities in parallel in an effort to maximize impact and accelerate discovery. Data-driven decisions and synthesis of insights allow us to pivot quickly when needed and uncover new opportunities.
4 Global Research Centers
Our four laboratories are the driving force of our research efforts. We pursue multiple technologies and modalities in parallel, in an effort to maximize impact and accelerate discovery.
Independent thinking, unified global vision
One Research Council
Our Research Council evaluates science and works together to proactively plan our IND pipeline. Each year at our global symposiums, our teams come together to share knowledge and ideas, discuss ongoing projects, and lend support across sites and areas of expertise.
Charting the course ahead
Cross-site Collaboration
We foster a collaborative ecosystem where individual teams work closely within their own labs, then come together to share insights, cross-pollinate ideas, and refine approaches through new perspectives.
Our cohesive ecosystem
Get to know Kelsey
Patient needs fuel our scientific discovery, which is why we make every decision as if a patient were in the room. Their stories ground us in what can come of breakthrough science. Hear from Kelsey to learn more about those who inspire us.
Discovery Dialogues
Sit down with members of Insmed’s global Research team as they discuss our approach to developing life-transforming therapies while tackling some of the most pressing scientific challenges today.
Disclaimer
These videos may contain forward-looking statements that involve substantial risks and uncertainties. “Forward-looking statements,” as that term is defined in the Private Securities Litigation Reform Act of 1995, are statements that are not historical facts and involve a number of risks and uncertainties. Words such as “may,” “will,” “should,” “could,” “would,” “expects,” “plans,” “anticipates,” “believes,” “estimates,” “projects,” “predicts,” “intends,” “potential,” “continues,” and similar expressions (as well as other words or expressions referencing future events, conditions or circumstances) may identify forward-looking statements.
Any forward-looking statements included are based upon the Company’s current expectations and beliefs, and involve known and unknown risks, uncertainties and other factors, which may cause the Company’s actual results, performance and achievements and the timing of certain events to differ materially from the results, performance, achievements or timings discussed, projected, anticipated or indicated in any forward-looking statements.
The Company may not actually achieve the results, plans, intentions or expectations indicated by the Company’s forward-looking statements because, by their nature, forward-looking statements involve risks and uncertainties because they relate to events and depend on circumstances that may or may not occur in the future. For additional information about the risks and uncertainties that may affect the Company’s business, please see the factors discussed in Item 1A, “Risk Factors,” in the Company’s most recently filed Annual Report on Form 10-K and any subsequent Company filings with the Securities and Exchange Commission (SEC).
The Company cautions viewers not to place undue reliance on any such forward-looking statements, which speak only as of the date the videos were recorded. The Company disclaims any obligation, except as specifically required by law and the rules of the SEC, to publicly update or revise any such statements to reflect any change in expectations or in events, conditions or circumstances on which any such statements may be based, or that may affect the likelihood that actual results will differ from those set forth in the forward-looking statements.
Business development
We actively seek opportunities to collaborate with forward-thinking teams across biotechnology and academia that share our sense of urgency and patient focus.
Clinical trials
To make a real-world impact, it’s vital that we understand real-life challenges. Our clinical trials are designed with input from patients to ensure their insights and needs are considered.
Your Privacy Choices